Beyond the Guidelines: Perspectives on the Role of PARP Inhibition in the Management of Ovarian Cancer — Faculty Presentation 4: Practical Considerations with the Use of PARP Inhibitors in Advanced OC — Dr Lheureux
CME information and select publications